Detection of progressive and regressive phase and LINE-1 retrotransposon in transfected dogs with transmissible venereal tumor during chemotherapy

J Vet Sci. 2018 Sep 30;19(5):620-626. doi: 10.4142/jvs.2018.19.5.620.

Abstract

Canine transmissible venereal tumor (CTVT) is a tumor that commonly occurs in genital and extragenital sites of both genders. Long interspersed nuclear elements (LINE-1) retrotransposon has a pivotal role in allogenic transfection among uncontrolled dog populations. This study aimed to perform pathomorphological, immunohistochemical, and in situ polymerase chain reaction (PCR) evaluation of CTVT (n = 18) in transfected dogs during chemotherapy. Immunohistochemically, tumor phases were investigated by using specific markers (CD3, CD4, CD8, CD79, and transforming growth factor beta [TGF-β]), and investigated an amplified specific sequence of TVT LINE-1 retrotransposon by in situ PCR. Polyhedral-shaped neoplastic cells that had large, round, hypo/hyperchromatic nuclei and eosinophilic cytoplasm were detected. All marker results were positive, especially in the early weeks of recovery. CD4 and TGF-β markers were conspicuously positive at the initial stage. In situ PCR LINE-1 sequence was initially positive in only four cases. It is believed that the CD and TGF-β markers provide phase identification at tumor initiation and during chemotherapy. It is thought that presence of T and B lymphocytes, which have roles in cellular and humoral immunity, is needed so that regression of the tumor is possible.

Keywords: antineoplastic agent; immunohistochemistry; long interspersed nuclear element-1; venereal tumors.

MeSH terms

  • Animals
  • Antigens, Differentiation, T-Lymphocyte / analysis
  • Biomarkers, Tumor / analysis*
  • CD79 Antigens / analysis
  • Dog Diseases / diagnosis*
  • Dog Diseases / metabolism
  • Dog Diseases / therapy
  • Dogs
  • Female
  • Long Interspersed Nucleotide Elements*
  • Male
  • Transfection / veterinary
  • Venereal Tumors, Veterinary / diagnosis*
  • Venereal Tumors, Veterinary / metabolism
  • Venereal Tumors, Veterinary / therapy

Substances

  • Antigens, Differentiation, T-Lymphocyte
  • Biomarkers, Tumor
  • CD79 Antigens